Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S M O'Reilly

Showing results (1-10 of 37) with videos related to

Pageof 4
Sort By:
BMJ (Clinical Research Ed.)|February 10, 1990
Node negative breast cancerS M O'Reilly, M A Richards
European Journal of Cancer (Oxford, England : 1990)|January 1, 1992
Is DNA flow cytometry a useful investigation in breast cancer?S M O'Reilly, M A Richards
BMJ (Clinical Research Ed.)|May 26, 1990
Node negative breast cancerS M O'Reilly, M A Richards
Journal of the Royal Society of Medicine|August 1, 1992
Breast cancer and liver metastases--incidence, diagnosis and outcomeC J Twelves, S M O'Reilly, M A Richards
Current Opinion in Obstetrics & Gynecology|February 1, 1993
Current approaches to diagnosis and treatment of gestational trophoblastic diseaseD B Smith, S M O'Reilly, E S Newlands
Cancer Chemotherapy and Pharmacology|January 1, 1989
Phase II study of mitoxantrone for liver metastases from breast cancerS M O'Reilly, R E Coleman, R D Rubens
European Journal of Cancer (Oxford, England : 1990)|January 1, 1990
Liver metastases from breast cancer: the relationship between clinical, biochemical and pathological features and survivalS M O'Reilly, M A Richards, R D Rubens
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 1, 1992
Single agent activity of carboplatin in patients with previously untreated non-seminomatous germ cell tumoursS M O'Reilly, G J Rustin, D B Smith, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
Dose intensification in the treatment of patients with testicular germ cell tumoursS M O'Reilly, D B Smith, E S Newlands, et al.
British Journal of Cancer|October 1, 1992
Flavone acetic acid (FAA) with recombinant interleukin-2 (TIL-2) in advanced malignant melanoma. II: Induction of nitric oxide productionL L Thomsen, B C Baguley, G J Rustin, et al.
Pageof 4

Showing results (1-10 of 37) with videos related to

Sort By:
Pageof 4
BMJ (Clinical Research Ed.)|February 10, 1990
Node negative breast cancerS M O'Reilly, M A Richards
European Journal of Cancer (Oxford, England : 1990)|January 1, 1992
Is DNA flow cytometry a useful investigation in breast cancer?S M O'Reilly, M A Richards
BMJ (Clinical Research Ed.)|May 26, 1990
Node negative breast cancerS M O'Reilly, M A Richards
Journal of the Royal Society of Medicine|August 1, 1992
Breast cancer and liver metastases--incidence, diagnosis and outcomeC J Twelves, S M O'Reilly, M A Richards
Current Opinion in Obstetrics & Gynecology|February 1, 1993
Current approaches to diagnosis and treatment of gestational trophoblastic diseaseD B Smith, S M O'Reilly, E S Newlands
Cancer Chemotherapy and Pharmacology|January 1, 1989
Phase II study of mitoxantrone for liver metastases from breast cancerS M O'Reilly, R E Coleman, R D Rubens
European Journal of Cancer (Oxford, England : 1990)|January 1, 1990
Liver metastases from breast cancer: the relationship between clinical, biochemical and pathological features and survivalS M O'Reilly, M A Richards, R D Rubens
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 1, 1992
Single agent activity of carboplatin in patients with previously untreated non-seminomatous germ cell tumoursS M O'Reilly, G J Rustin, D B Smith, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
Dose intensification in the treatment of patients with testicular germ cell tumoursS M O'Reilly, D B Smith, E S Newlands, et al.
British Journal of Cancer|October 1, 1992
Flavone acetic acid (FAA) with recombinant interleukin-2 (TIL-2) in advanced malignant melanoma. II: Induction of nitric oxide productionL L Thomsen, B C Baguley, G J Rustin, et al.
Pageof 4